Getein Biotech, Inc (603387.SS)
CNY 7.95
(0.25%)
CNY 7.95
(0.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 182.34 Million CNY | 430.15% |
| 2022 | -55.23 Million CNY | 88.31% |
| 2021 | -472.43 Million CNY | -13.37% |
| 2020 | -416.71 Million CNY | 26.18% |
| 2019 | -564.47 Million CNY | -394.42% |
| 2018 | -114.17 Million CNY | 62.07% |
| 2017 | -301.02 Million CNY | -1046.45% |
| 2016 | -26.25 Million CNY | -129.75% |
| 2015 | -11.42 Million CNY | -39.4% |
| 2014 | -8.19 Million CNY | 22.17% |
| 2013 | -10.53 Million CNY | 47.3% |
| 2012 | -19.98 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 225.85 Million CNY | 23.86% |
| 2024 Q3 | 141.19 Million CNY | -18.78% |
| 2024 Q2 | 165.96 Million CNY | -26.52% |
| 2023 Q1 | -148.91 Million CNY | -169.62% |
| 2023 FY | 182.34 Million CNY | 430.15% |
| 2023 Q3 | 359.04 Million CNY | 156.24% |
| 2023 Q2 | 140.12 Million CNY | 194.09% |
| 2023 Q4 | 182.34 Million CNY | -49.21% |
| 2022 Q3 | -473.53 Million CNY | -11.95% |
| 2022 Q2 | -422.99 Million CNY | 11.02% |
| 2022 FY | -55.23 Million CNY | 88.31% |
| 2022 Q1 | -475.38 Million CNY | -0.62% |
| 2022 Q4 | -55.23 Million CNY | 88.34% |
| 2021 Q3 | -558.62 Million CNY | -3.16% |
| 2021 Q2 | -541.49 Million CNY | -30.0% |
| 2021 Q1 | -416.51 Million CNY | 0.05% |
| 2021 Q4 | -472.43 Million CNY | 15.43% |
| 2021 FY | -472.43 Million CNY | -13.37% |
| 2020 Q1 | -659.42 Million CNY | -16.82% |
| 2020 Q2 | -216.45 Million CNY | 67.18% |
| 2020 Q4 | -416.71 Million CNY | -16.19% |
| 2020 Q3 | -358.65 Million CNY | -65.7% |
| 2020 FY | -416.71 Million CNY | 26.18% |
| 2019 Q2 | -191.41 Million CNY | -25.78% |
| 2019 FY | -564.47 Million CNY | -394.42% |
| 2019 Q4 | -564.47 Million CNY | -208.76% |
| 2019 Q3 | -182.82 Million CNY | 4.49% |
| 2019 Q1 | -152.17 Million CNY | -4.65% |
| 2018 Q3 | -180.47 Million CNY | 34.43% |
| 2018 FY | -114.17 Million CNY | 62.07% |
| 2018 Q4 | -145.4 Million CNY | 19.43% |
| 2018 Q2 | -275.25 Million CNY | -1.09% |
| 2018 Q1 | -272.28 Million CNY | 9.55% |
| 2017 Q1 | -45.94 Million CNY | -74.99% |
| 2017 Q3 | -289.75 Million CNY | -653.86% |
| 2017 Q4 | -301.02 Million CNY | -3.89% |
| 2017 FY | -301.02 Million CNY | -1046.45% |
| 2017 Q2 | -38.43 Million CNY | 16.34% |
| 2016 Q4 | -26.25 Million CNY | 0.0% |
| 2016 FY | -26.25 Million CNY | -129.75% |
| 2015 FY | -11.42 Million CNY | -39.4% |
| 2015 Q1 | -16.3 Million CNY | 0.0% |
| 2014 FY | -8.19 Million CNY | 22.17% |
| 2013 FY | -10.53 Million CNY | 47.3% |
| 2012 FY | -19.98 Million CNY | 0.0% |